LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 283 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 6.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $28,000 | -89.2% | 290 | -87.5% | 0.00% | -100.0% |
| Q2 2020 | $259,000 | +77.4% | 2,314 | +14.3% | 0.00% | +100.0% |
| Q1 2020 | $146,000 | -85.0% | 2,024 | -78.4% | 0.00% | -75.0% |
| Q4 2019 | $976,000 | -58.1% | 9,360 | -60.1% | 0.00% | -63.6% |
| Q3 2019 | $2,332,000 | -36.5% | 23,433 | -27.1% | 0.01% | -31.2% |
| Q2 2019 | $3,672,000 | -80.1% | 32,164 | -78.1% | 0.02% | -80.5% |
| Q1 2019 | $18,475,000 | +9.4% | 146,964 | +18.1% | 0.08% | +3.8% |
| Q4 2018 | $16,891,000 | -50.4% | 124,470 | +0.4% | 0.08% | -38.3% |
| Q3 2018 | $34,043,000 | +28.3% | 124,023 | -3.2% | 0.13% | +21.9% |
| Q2 2018 | $26,531,000 | +30.7% | 128,062 | +4.2% | 0.10% | +31.2% |
| Q1 2018 | $20,294,000 | +21.0% | 122,875 | +0.4% | 0.08% | +27.0% |
| Q4 2017 | $16,766,000 | -4.2% | 122,440 | -4.7% | 0.06% | -8.7% |
| Q3 2017 | $17,493,000 | +10.5% | 128,485 | -1.5% | 0.07% | +7.8% |
| Q2 2017 | $15,834,000 | +14.6% | 130,426 | -0.0% | 0.06% | +10.3% |
| Q1 2017 | $13,811,000 | -4.8% | 130,491 | -8.6% | 0.06% | -12.1% |
| Q4 2016 | $14,506,000 | -0.8% | 142,762 | -0.3% | 0.07% | -5.7% |
| Q3 2016 | $14,616,000 | -34.6% | 143,214 | -23.6% | 0.07% | -36.9% |
| Q2 2016 | $22,365,000 | +5.9% | 187,517 | -4.9% | 0.11% | +5.7% |
| Q1 2016 | $21,126,000 | -1.9% | 197,271 | -0.7% | 0.10% | -0.9% |
| Q4 2015 | $21,532,000 | +31.4% | 198,597 | +3.8% | 0.11% | +21.8% |
| Q3 2015 | $16,387,000 | -4.0% | 191,331 | +13.1% | 0.09% | +1.2% |
| Q2 2015 | $17,065,000 | +28.3% | 169,124 | -1.9% | 0.09% | +26.5% |
| Q1 2015 | $13,298,000 | +56.2% | 172,455 | +7.8% | 0.07% | +54.5% |
| Q4 2014 | $8,512,000 | +17.9% | 159,976 | +4.1% | 0.04% | +25.7% |
| Q3 2014 | $7,222,000 | -47.9% | 153,700 | -30.9% | 0.04% | -47.8% |
| Q2 2014 | $13,850,000 | -24.3% | 222,341 | -18.3% | 0.07% | -22.1% |
| Q1 2014 | $18,306,000 | +41.2% | 272,172 | +10.4% | 0.09% | +43.3% |
| Q4 2013 | $12,962,000 | +72.9% | 246,432 | +42.3% | 0.06% | +62.2% |
| Q3 2013 | $7,496,000 | +8.5% | 173,197 | -6.2% | 0.04% | +5.7% |
| Q2 2013 | $6,911,000 | – | 184,710 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 1,249,766 | $58,726,504,000 | 11.17% |
| BVF INC/IL | 1,108,763 | $52,101,000 | 10.82% |
| GROW Partners, LLC | 132,500 | $6,226,000 | 5.58% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 936,825 | $44,021,000 | 2.73% |
| First Light Asset Management, LLC | 76,366 | $3,588,000 | 2.45% |
| Healthcare Value Capital, LLC | 50,000 | $2,350,000 | 2.27% |
| OBERWEIS ASSET MANAGEMENT INC/ | 168,337 | $7,910,000 | 2.17% |
| RK Capital | 174,283 | $8,190,000 | 1.67% |
| Nichols Asset Management LLC | 133,368 | $6,267,000 | 1.30% |
| ASHFORD CAPITAL MANAGEMENT INC | 108,289 | $5,089,000 | 1.09% |